Cefotan

Active Ingredient(s): Cefotetan
FDA Approved: * December 27, 1985
Pharm Company: * ASTRAZENECA
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cefotan Overview

Cefotetan is an injectable antibiotic of the cephamycin type for prophylaxis and treatment of bacterial infections. It is often grouped together with second-generation cephalosporins and has a similar antibacterial spectrum, but with additional anti-anaerobe coverage. Cefotetan was developed by Yamanouchi. It is marketed outside Japan by AstraZeneca with the brand names Apatef and Cefotan. Contents 1 Adverse effects 2 Spectrum of bacterial susceptibility 3 References 4 External links ...

Read more Cefotan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cefotetan

Recent Cefotan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Cefotan: (2 results)

Sorted by National Drug Code

• 52565-052 Cefotan 1 g/10ml Intramuscular; Intravenous Injection, Powder, for Solution by Teligent Pharma, Inc.
• 52565-053 Cefotan 2 g/20ml Intramuscular; Intravenous Injection, Powder, for Solution by Teligent Pharma, Inc.

Other drugs which contain Cefotetan or a similar ingredient: (1 result)

• CEFOTETAN